Article ID Journal Published Year Pages File Type
10011584 Journal of the American Academy of Dermatology 2005 7 Pages PDF
Abstract
Treatment of atopic dermatitis with pimecrolimus cream 1% in early childhood does not appear to interfere with the development of a normal immune response to vaccinations.
Related Topics
Health Sciences Medicine and Dentistry Dermatology
Preview
Long-term treatment of atopic dermatitis with pimecrolimus cream 1% in infants does not interfere with the development of protective antibodies after vaccination
Authors
, , , , , , , , , , , ,